Search

everythinglearnresearchcommunity

for

Search:↓

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Women may need different blood pressure guidelines than men for heart disease prevention.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.